Migraine - Chronic
Rahul Soman, M. Pharm
Definition
A primary episodic headache disorder characterized by various combinations of neurological, gastrointestinal, and autonomic changes . Migraines may have common (without aura), classic (with aura), or complex (basilar, hemiplegic, ophthalmoplegic, abdominal) presentations.
Medical History
* Dietary intake finding
* Alcohol intake - finding
* Menstruation finding
* Hormonal Contraceptive use
* Menopause [Menopause - Chronic]
* Estrogen/Progestin Combination use
* Antihypertensive use
* Exercise history finding
* Whiplash injury to neck
* Blunt head trauma
* Smoking
* Cocaine abuse
* Environmental finding
* Family history of Migraine
Findings
* Headache
* Nausea
* Mood disorder
* Vomiting
* Light intolerance
* Blurred vision
* Tachyarrhythmia
* Visual obscuration
* Visual field defect
* Pain in eye
* Noise intolerance
* Abdominal pain
* Abdominal distension, gaseous
* Aphasia
* Carotid artery finding
* Fatigue
* Paresthesia
* Scalp tenderness
* Weight gain
* Hyperventilation
* Edema
* Engorgement of vein
* Altered mental status
* Ataxia
* Chest pain
* Pallor
* Nuchal rigidity
* Myalgia
* Vertigo
* Syncope
* Hypesthesia
* Hemiplegia
* Nasal congestion
* Diarrhea
* Seizure
* Homonymous hemianopia
* Third cranial nerve weakness
* Diplopia
* Dysarthria
* Neck pain
* Increased body temperature
Tests
Headache
* Imaging by body site, Entire brain: Neuroimaging may aid in differential diagnosis of some patients by ruling out specific intracranial abnormalities , but is not universally recommended in all patients with all headache types .
Suspected subarachnoid hemorrhage in patients with a negative or equivocal head CT scan
* Cerebrospinal fluid examination: Findings consistent with subarachnoid hemorrhage include elevated opening pressure, elevated RBC count that does not diminish in successive tubes, and xanthochromia .
Meningitis
* Cerebrospinal fluid examination
Suspected giant cell (temporal) arteritis
* Erythrocyte sedimentation rate measurement: Erythrocyte sedimentation rate is elevated in most, but not all, patients with giant cell arteritis; a normal result does not exclude disease .
Differential Diagnosis
* Subarachnoid hemorrhage
* Thromboembolic stroke
* Transient ischemic attack - Acute
* Intracranial hemorrhage
* Bacterial meningitis - Acute
* Viral meningitis - Acute
* Viral encephalitis - Acute
* Temporal arteritis
* Intracranial tumor
* Carotid artery dissection
* Vertebral artery dissection
* Cluster headache - Acute
* Abscess of brain - Acute
* Hydrocephalus
* Pseudotumor cerebri - Acute
* Trigeminal neuralgia - Acute
* Sinusitis - Acute
* Tension-type headache
* Temporomandibular joint-pain-dysfunction syndrome
* Optic neuritis
* Postconcussion syndrome
* Amaurosis fugax
* Low pressure headache
* Vasculitis
* Pheochromocytoma - Acute
* Glaucoma - Acute
Treatment
Drug Therapy
Prevention of migraine
PROPRANOLOL HYDROCHLORIDE
Adults: 80 to 240 mg/day orally
TIMOLOL MALEATE
Adults: 20 to 30 mg/day orally
AMITRIPTYLINE HYDROCHLORIDE
Adults: 30 to 150 mg/day orally
DIVALPROEX SODIUM
Adults: 500 to 1500 mg/day orally
VALPROATE SODIUM
Adults: 800 to 1500 mg/day orally
TOPIRAMATE
Adults: 100 mg/day orally in 2 divided doses; recommended titration rate is 25 mg in the evening for 1 week, 25 mg twice daily for 1 week, 25 mg in the morning and 50 mg in the evening for 1 week, and then 50 mg twice daily
Procedural Therapy
Headache
* Biofeedback, thermal: Thermal biofeedback plus relaxation, alone, or in combination with prophylactic drug therapy for headache may be effective in some patients .
Headache
* Cognitive - behavior therapy: Cognitive-behavioral therapy, alone, or in combination with prophylactic drug therapy for headache may be effective in some patients .
Headache
* Electromyographic biofeedback: Electromyographic biofeedback, alone, or in combination with prophylactic drug therapy for headache may be effective in some patients .
Non-Procedural Therapy
Migraine
* Risk Factor Modification
* Self-Massage
* Progressive Relaxation
* Decreased Environmental Stimulation
No comments:
Post a Comment